The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 347:1978-1980 December 12, 2002 Number 24
NextNext

Toll-like Receptor 4 Polymorphisms and Atherogenesis

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Kiechl, S.
-PubMed Citation
To the Editor: Kiechl and colleagues (July 18 issue)1 provide interesting evidence that the toll-like receptor 4 (TLR4) 896G (299Gly) polymorphism may confer susceptibility to bacterial infection. As part of ongoing collaborative projects,2,3,4 we have investigated the role of this polymorphism in a large United Kingdom study of invasive pneumococcal disease and a large West African study of pulmonary tuberculosis. There was no evidence of an association between the TLR4 896G allele and invasive pneumococcal disease or pulmonary tuberculosis (Table 1). These data add to the findings of Read et al.5 that the TLR4 896G polymorphism was not . . . [Full Text of this Article]


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.